KIA
RMD icon

Knollwood Investment Advisory’s ResMed RMD Stock Holding History

Knollwood Investment Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Hold
6,450
– – 0.15% 130
2025
Q4 		$1.55M Hold
6,450
– – 0.15% 139
2025
Q3 		$1.77M Hold
6,450
– – 0.16% 130
2025
Q2 		$1.66M Hold
6,450
– – 0.16% 140
2025
Q1 		$1.44M Hold
6,450
– – 0.16% 147
2024
Q4 		$1.48M Hold
6,450
– – 0.15% 149
2024
Q3 		$1.57M Hold
6,450
– – 0.17% 145
2024
Q2 		$1.23M Buy
+6,450
New +$1.31M 0.14% 164

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Knollwood Investment Advisory's RMD Position: Q1 2026 in Review

Knollwood Investment Advisory held its ResMed (RMD) position steady in Q1 2026 at 6,450 shares worth $1.45M. The position accounts for 0.15% of the portfolio, ranked #130.

Knollwood Investment Advisory first reported a position in RMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.77M in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Knollwood Investment Advisory held 6,450 shares of ResMed worth $1.45M as of Q1 2026.
  • Knollwood Investment Advisory left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.15% of Knollwood Investment Advisory's portfolio in Q1 2026, its #130 holding.
  • Knollwood Investment Advisory first reported a position in ResMed in Q2 2024 and has held it in 8 quarters since.
  • Knollwood Investment Advisory's ResMed position peaked at $1.77M in Q3 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.